First ARVs from state-owned pharmaceutical company expected by 2017
As the world’s biggest consumer of ARVs, South Africa spends billions of rands purchasing the drugs on the international market every year.
Ketlaphela
No image available
New state-run pharmaceutical company to produce ARVs by 2019
South Africa will soon get its own facility to make tablets to treat HIV and other ailments.
